Voriconazole: Best Treatment for Invasive Fusariosis in 2025
Wondering how doctors tackle invasive fusariosis? This article digs into how voriconazole is changing the game for patients with this tricky fungal infection in 2025. You'll get real facts, data, tips for recognising symptoms, and the latest on what makes this drug stand out among antifungal therapies. Catch up with clinical cases and important advice for navigating treatment options. The insights will help you understand the stakes—and the promise—of using voriconazole for Fusarium infections.
- May 5 2025
- Jasper Thorneville
- Permalink
Elsevier Resumes Review of Debated Hydroxychloroquine COVID-19 Research
Elsevier has reignited an examination of a controversial study on hydroxychloroquine's impact on COVID-19 patients, originally published in *The Lancet*. The research, which significantly influenced global health policies, faced intense criticism over methodology and data reliability provided by Surgisphere. This renewed investigation aims to clarify the study's integrity and its influence on public health decisions.
- July 30 2024
- Jasper Thorneville
- Permalink
- Elsevier Hydroxychloroquine COVID-19 Surgical Research
- 0 Comments